Loading
Hiv / Control condition / B2B Intervention · Interventional Study
ClinicalTrials.gov · August 13, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned feasibility and acceptability study of a peer-delivered, multicomponent behavioral intervention (Bridge to Belonging) designed to reduce loneliness and depression in older gay and bisexual men living with HIV. No results have been posted in this registry record; the study is currently recruiting and enrollment is anticipated to close in September 2026.
Interventional, Randomized, Parallel, Open label, Treatment purpose. HIV; age from 50 Years. Intervention: B2B Intervention. Compared with: Control — Active Comparator. n = 40. 1 site: United States.
This is a planned feasibility and acceptability study of a peer-delivered, multicomponent behavioral intervention (Bridge to Belonging) designed to reduce loneliness and depression in older gay and bisexual men living with HIV. No results have been posted in this registry record; the study is currently recruiting and enrollment is anticipated to close in September 2026.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
No clinical impact can be assessed until results are published. This study measures feasibility and acceptability, not efficacy; any future clinical utility depends on completion and positive preliminary findings.
This is a registry record for a feasibility and acceptability study of a peer-led behavioral intervention in an early recruitment phase, with no results posted.
As stated by the source record.
Quoted from the source exactly as published.
No clinical impact can be assessed until results are published. This study measures feasibility and acceptability, not efficacy; any future clinical utility depends on completion and positive preliminary findings.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07762066). This is a study registration, not published results. Lead sponsor: Fenway Community Health. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 40 participants (ESTIMATED). Conditions: HIV. Interventions: BEHAVIORAL: B2B Intervention; BEHAVIORAL: Control condition. Primary outcome measures: Feasibility of recruitment , Through end of enrollment, anticipated September 7, 2026; Proportion of Intervention-Arm Participants Completing at Least One B2B Session , Up to 11 weeks; Perceived Feasibility and Satisfaction with B2B, Assessed via Qualitative Exit Interviews , Week 25; Fidelity to B2B Intervention Content, Assessed via Post-Session Fidelity Checklist , Up to 11 weeks; B2B Intervention Satisfaction, Assessed via Modified Client Satisfaction Questionnaire (CSQ-8) , Up to 11 weeks; Retention Feasibility, Proportion of Enrolled Participants Completing Follow-Up Assessment , Through Week 25. Brief summary: Older gay and bisexual men living with HIV (OGBMLH) are more likely to experience depression and loneliness, which can lead to negative health outcomes. This mixed-methods research study will assess the feasibility and acceptability of the Bridge to Belonging (B2B) intervention. B2B is a peer-delivered, manualized program designed to increase engagement in LGBTQ+-affirming elder services and thereby reduce loneliness and depression among OGBMLH. The program utilizes a) cognitive behavioral therapy-based Friendship Enrichment Program (FEP) to build social skills; b) Peer Mentoring (PM) to model and support engagement in community services; and c) connecting participants to affirming elder services such as meal programs, bereavement groups, social activities, etc. Interventions like B2B are essential to the NIH's goal of improving access to behavioral interventions through advances in HIV/AIDS research.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.